Kimia Therapeutics
Latest round
- Series A
Last raised
- Aug 2023
Total raised
- $60M
Investors
- 3
About Kimia Therapeutics
Based in California, US, and founded in 2023, Kimia Therapeutics Inc operates as a biotechnology research company that offers a biotechnology platform that develops chemical atlas for the treatment of human diseases. In December 2023, Kimia Therapeutics, Inc. The company was Co-founded by its CEO and president Stig K. Hansen, Jack Sadowsky, and Ray Fucini. The company offers generative chemistry which is based on successive iterations of chemical design using synthesis, chemical biology, and machine learning. The firm provides deeper insights from empirical data for the development of medicines. for metabolic programs.
Who invested in Kimia Therapeutics
3 investors across 1 round
See all investors in Kimia Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 9, 2023
Amount
$60M
Investors
Questions about Kimia Therapeutics
Who invested in Kimia Therapeutics?
Kimia Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kimia Therapeutics raised?
Kimia Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Kimia Therapeutics last raise money?
Kimia Therapeutics's most recent round on record is a Series A, in Aug 2023.
What does Kimia Therapeutics do?
Based in California, US, and founded in 2023, Kimia Therapeutics Inc operates as a biotechnology research company that offers a biotechnology platform that develops chemical atlas for the treatment of human diseases.
Where is Kimia Therapeutics headquartered?
Kimia Therapeutics is headquartered in Berkeley, US.
Which VCs invest in companies like Kimia Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Kimia Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Kimia Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.